Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update

There is an emerging body of evidence regarding the use of immunotherapy in early-stage triple negative breast cancer (TNBC), with the recent publication of several phase III and randomised phase II studies examining the role of immune checkpoint inhibitors (ICI) in the neoadjuvant setting in combin...

Full description

Saved in:
Bibliographic Details
Main Authors: Lauren C. Brown, Sherene Loi
Format: Artigo
Language:Inglês
Published: Elsevier 2022-03-01
Series:Breast
Subjects:
Early breast cancer
Triple negative breast cancer
Immune checkpoint inhibition
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621010250
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items